Literature DB >> 29558355

[Cutaneous polyarteritis nodosa].

Monika Turska1, Jolanta Parada-Turska2.   

Abstract

Cutaneous polyarteritis nodosa is a rare disease that affects vessels of the deep skin and the subcutaneous tissue. Its etiopathology remains unknown. It predominantly affects skin, and the main cutaneous symptoms are subcutaneous nodules, livedo reticularis, and ulcerations that are mainly located on legs. Cutaneous polyarteritis nodosa can also cause extracutaneous symptoms (fever, malaise, myalgias, arthralgias, neuropathy). It is a chronic benign disease with a relapsing course. Diagnostic criteria for this disease were recently proposed and both clinical and typical histological features must be present to confirm the diagnosis. Treatment of cutaneous polyarteritis nodosa depends on the severity of the disease and the frequency of relapses. Mild forms limited to skin lesions should be treated with nonsteroidal anti-inflammatory drugs, colchicine and locally applied glucocorticosteroids. Cases that are refractory to the treatment, that recur with extracutaneous symptoms may require applying more aggressive approach (glucocorticosteroids orally, hydroxychloroquine, azathioprine, methotrexate, mycophenolate mofetil or intravenous immunoglobulins). The prognosis in cutaneous polyarteritis nodosa is favorable and the disease rarely turns into a systemic form.

Entities:  

Keywords:  cutenous polyarteritis nodosa; nodules, ulcerations; polyarteritis nodosa; treatment; livedo reticularis

Mesh:

Year:  2018        PMID: 29558355

Source DB:  PubMed          Journal:  Wiad Lek        ISSN: 0043-5147


  2 in total

1.  Cutaneous polyarteritis nodosa in a 7-year-old boy: difficulties in diagnosis.

Authors:  Izabela Dybowska-Gołota; Magdalena Krajewska-Włodarczyk; Zbigniew Żuber
Journal:  Reumatologia       Date:  2019-10-31

2.  Dermatological Manifestations in Pediatric Inflammatory Bowel Disease.

Authors:  Smaranda Diaconescu; Silvia Strat; Gheorghe G Balan; Carmen Anton; Gabriela Stefanescu; Ileana Ioniuc; Ana Maria Alexandra Stanescu
Journal:  Medicina (Kaunas)       Date:  2020-08-23       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.